|
1
|
Kumari P, Inoue A, Chapman K, Lian P, Rosenbaum DM. Molecular mechanism of fatty acid activation of FFAR1. Proc Natl Acad Sci U S A 2023; 120:e2219569120. [PMID: 37216523 PMCID: PMC10235965 DOI: 10.1073/pnas.2219569120] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Accepted: 04/03/2023] [Indexed: 05/24/2023] Open
Abstract
FFAR1 is a G-protein-coupled receptor (GPCR) that responds to circulating free fatty acids to enhance glucose-stimulated insulin secretion and release of incretin hormones. Due to the glucose-lowering effect of FFAR1 activation, potent agonists for this receptor have been developed for the treatment of diabetes. Previous structural and biochemical studies of FFAR1 showed multiple sites of ligand binding to the inactive state but left the mechanism of fatty acid interaction and receptor activation unknown. We used cryo-electron microscopy to elucidate structures of activated FFAR1 bound to a Gq mimetic, which were induced either by the endogenous FFA ligand docosahexaenoic acid or γ-linolenic acid and the agonist drug TAK-875. Our data identify the orthosteric pocket for fatty acids and show how both endogenous hormones and synthetic agonists induce changes in helical packing along the outside of the receptor that propagate to exposure of the G-protein-coupling site. These structures show how FFAR1 functions without the highly conserved "DRY" and "NPXXY" motifs of class A GPCRs and also illustrate how the orthosteric site of a receptor can be bypassed by membrane-embedded drugs to confer full activation of G protein signaling.
Collapse
Affiliation(s)
- Punita Kumari
- Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX75390
| | - Asuka Inoue
- Department of Pharmaceutical Sciences, Tohoku University, Sendai980-8578, Japan
| | - Karen Chapman
- Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX75390
| | - Peng Lian
- BioHPC at the Lyda Hill Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX75390
| | - Daniel M. Rosenbaum
- Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX75390
| |
Collapse
|
|
2
|
Pavlík V, Machalová V, Čepa M, Šínová R, Šafránková B, Kulhánek J, Drmota T, Kubala L, Huerta-Ángeles G, Velebný V, Nešporová K. Retinoic Acid Grafted to Hyaluronic Acid Activates Retinoid Gene Expression and Removes Cholesterol from Cellular Membranes. Biomolecules 2022; 12:biom12020200. [PMID: 35204701 PMCID: PMC8961547 DOI: 10.3390/biom12020200] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/12/2022] [Accepted: 01/20/2022] [Indexed: 02/05/2023] Open
Abstract
All-trans-retinoic acid (atRA) is a potent ligand that regulates gene expression and is used to treat several skin disorders. Hyaluronic acid (HA) was previously conjugated with atRA (HA-atRA) to obtain a novel amphiphilic compound. HA-atRA forms micelles that incorporate hydrophobic molecules and facilitate their transport through the skin. The aim of this study was to determine the influence of HA-atRA on gene expression in skin cells and to compare it with that of unbound atRA. Gene expression was investigated using microarrays and a luciferase system with a canonical atRA promoter. HA-atRA upregulated gene expression similarly to atRA. However, HA-atRA activated the expression of cholesterol metabolism genes, unlike atRA. Further investigation using HPLC and filipin III staining suggested that the treated cells induced cholesterol synthesis to replenish the cholesterol removed from the cells by HA-atRA. HA modified with oleate (HA-C18:1) removed cholesterol from the cells similarly to HA-atRA, suggesting that the cholesterol removal stemmed from the amphiphilic nature of the two derivatives. HA-atRA induces retinoid signaling. Thus, HA-atRA could be used to treat skin diseases, such as acne and psoriasis, where the combined action of atRA signaling and anti-inflammatory cholesterol removal may be potentially beneficial.
Collapse
Affiliation(s)
- Vojtěch Pavlík
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
- Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic
- Correspondence:
| | - Veronika Machalová
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
| | - Martin Čepa
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
| | - Romana Šínová
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
- Institute of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic;
| | - Barbora Šafránková
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
| | - Jaromír Kulhánek
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
| | - Tomáš Drmota
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
| | - Lukáš Kubala
- Institute of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic;
- International Clinical Research Center, St. Anne’s University Hospital, 656 91 Brno, Czech Republic
| | - Gloria Huerta-Ángeles
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
| | - Vladimír Velebný
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
| | - Kristina Nešporová
- R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic; (V.M.); (M.Č.); (R.Š.); (B.Š.); (J.K.); (T.D.); (G.H.-Á.); (V.V.); (K.N.)
| |
Collapse
|
|
3
|
Song BJ, Elbert A, Rahman T, Orr SK, Chen CT, Febbraio M, Bazinet RP. Genetic Ablation of CD36 Does not Alter Mouse Brain Polyunsaturated Fatty Acid Concentrations. Lipids 2010; 45:291-9. [DOI: 10.1007/s11745-010-3398-z] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2009] [Accepted: 02/08/2010] [Indexed: 12/30/2022]
|